Clinical Research Agreement Template for Switzerland

A Clinical Research Agreement (CRA) is a legally binding contract that establishes the framework for conducting clinical trials and research studies involving human participants in Switzerland. This comprehensive document governs the relationship between multiple parties, including research institutions, pharmaceutical sponsors, principal investigators, and contract research organizations, ensuring that all clinical research activities comply with Swiss regulatory requirements and international standards.

When do you need this document?

You need a Clinical Research Agreement whenever you're planning to conduct clinical trials or research involving human subjects in Switzerland. This includes pharmaceutical companies testing new medications, medical device manufacturers conducting safety studies, research institutions investigating treatment protocols, or academic centers performing observational studies. The agreement is mandatory before initiating any research activities and must be in place before submitting applications to ethics committees or Swissmedic. You'll also need this document when establishing partnerships between multiple research sites, engaging contract research organizations, or when international sponsors collaborate with Swiss institutions to conduct multi-center studies.

Key legal considerations

Several critical legal provisions must be carefully addressed in your Clinical Research Agreement. Liability allocation is paramount, as Swiss law requires specific insurance coverage for research-related injuries and clear delineation of responsibility between sponsors and investigators. Data protection clauses must comply with the Federal Act on Data Protection, establishing protocols for collecting, processing, and transferring personal health information of research subjects. Intellectual property rights need precise definition, particularly regarding study data ownership, publication rights, and invention disclosures. Financial arrangements should detail payment schedules, cost coverage, and budget allocations while ensuring compliance with Swiss healthcare regulations. Termination provisions must address early study cessation, data handling upon termination, and ongoing obligations to research participants.

Legal requirements in Switzerland

Swiss clinical research agreements must comply with the Human Research Act (HRA), which establishes fundamental requirements for research involving human beings, including consent procedures, risk-benefit assessments, and subject protection measures. The Clinical Trials Ordinance provides detailed implementation requirements, specifying approval procedures, reporting obligations, and safety monitoring protocols that must be incorporated into your agreement. Compliance with the Therapeutic Products Act is essential when testing medicinal products or medical devices, requiring adherence to Good Clinical Practice guidelines and Swissmedic regulations. Your agreement must also address cantonal healthcare laws, as research conducted in healthcare institutions may be subject to additional regional requirements. Ethics committee approval procedures must be clearly outlined, including protocols for protocol amendments and adverse event reporting to ensure ongoing compliance throughout the study duration.